Sorry, you need to enable JavaScript to visit this website.
    Medicines

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin Injuries

 

FOR IMMEDIATE RELEASE- New York, N.Y., November 26, 2018 – Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling six lots of ThermaCare® HeatWrap product to the consumer level. Pfizer Consumer Healthcare initiated this recall because product from these lots has a potential to leak ingredients that are contained in the heat cell wrap.

The use of a leaking/damaged heat cell wrap could cause skin injuries such as burns/blisters and/or skin irritation on the wrap applied area. The product label warns not to use the product if heat cell contents leak and/or the wrap is damaged or torn.

ThermaCare® Muscle Pain Therapy provides heat therapy for temporary relief of minor muscular aches and pains associated with overexertion, strains, sprains, and arthritis. ThermaCare® Menstrual Pain Therapy provides heat therapy for temporary relief of minor menstrual cramp pain and associated backaches.

The ThermaCare® HeatWrap lots impacted are S68516 (Muscle Pain Therapy 3+1 count carton), T26686 (Muscle Pain Therapy 3 count carton), T26691 (Menstrual Pain Therapy 3 count carton), T26693 (Menstrual Pain Therapy 3+1 count carton); and 8054HA and 8054HB (11 count bundled packages contain one (1) package of Muscle Therapy Heatwraps, 8HR (3 Count) and two (2) packages of Joint Therapy Heatwraps, 8HR (4 Count)). Please note ThermaCare® Joint Therapy Heatwraps, 8HR are not subject to this recall notification.

These lots were distributed nationwide to retailers, wholesalers and distributors in the United States, Puerto Rico and the U.S. Virgin Islands from September 2017 through August 2018.

ThermaCare® HeatWrap Lot and Packaging Information

Product NameLot NumberExpiry DateSKUUPCConfiguration /Count
Muscle Pain Therapy 8HRS685162020-07F005733013143057330131443 + 1 one-time use wraps per carton
Muscle Pain Therapy 8HRT266862020-07F00573301303C3057330130383 one-time use wraps per carton
Muscle Pain Therapy 8HRT266912020-07F0057332002H3057330200293 one-time use wraps per carton
Muscle Pain Therapy 8HRT266932020-08F005733020443057330204493 + 1 one-time use wraps per carton

 

Bundled Lots

Product NameBundled Lot NumberCarton/ Pouch Lot NumberExpiry DateSKUUPCConfiguration/ Count
Joint/Muscle Pain Therapy 8HR8054HAT266862020-07F00573301311305733013113ulti-pack 11 one-time use wraps per carton
Joint/Muscle Pain Therapy 8HR8054HBT266862020-07F00573301311305733013113ulti-pack 11 one-time use wraps per carton

Pfizer Inc. places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process.
Product Name Bundled Lot Number Carton/ Pouch Lot Number Expiry Date SKU UPC Configuration/ Count Joint/Muscle Pain Therapy 8HR 8054HA T26686 2020-07 F00573301311 305733013113 Multi-pack 11 one-time use wraps per carton Joint/Muscle Pain Therapy 8HR 8054HB T26686 2020-07 F00573301311 305733013113 Multi-pack 11 one-time use wraps per carton Pfizer Consumer Healthcare is notifying consumers of this recall with this public notification. Pfizer Consumer Healthcare has already notified its retailers of this recall on October 2, 2018 and has provided instructions for the return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lot being recalled should stop use and distribution and quarantine the product immediately. Wholesalers, distributors and retailers who have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. For retailer instructions on returning product or additional assistance, call Stericycle at 1-800-805-3093 between the hours of 8 a.m. to 5 p.m. ET, Monday through Friday.

Pfizer Consumer Healthcare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to discontinue use of the products, record the lot number, throw the product away in its entirety without opening the foil pouch, and to please contact the Pfizer Consumer Healthcare Information Line at 1-800-323-3383 (Mon-Fri, 9am-5pm EST) for replacement or reimbursement. Note: The lot numbers can be found on the side of ThermaCare cartons and on the back of ThermaCare pouches.

If consumers have questions regarding this recall or to report an adverse event or product complaint, contact the Pfizer Consumer Healthcare Information Line at 1-800-323-3383 (Mon-Fri, 9am-5pm EST).

Consumers should contact their healthcare provider if they have experienced any problems that may be related to using this product.

Adverse reactions or quality problems experienced with the use of this product may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being executed with the knowledge of the U.S. Food and Drug Administration.

# # # # # 

Pfizer Inc.
Media Contact:
Jessica Smith, 212 733 6213; [email protected]

Sign up for the latest Pfizer Wire news alerts

Receive real-time updates on Pfizer’s news delivered directly to your inbox.

Our Pipeline: Potential Breakthroughs in the Making

We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

Coronavirus Resources

Learn about SARS-CoV-2, the coronavirus that causes COVID-19, what you can do to stay safe and prevent the spread, and our scientific efforts to help bring an end to the current global health crisis.

Making the COVID-19 Oral Treatment

How 2,000+ Pfizer team members made it happen.

Product Hub

Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and 30+ clinical trials, all before its first prescription.

Paxlovid Manufacturing B-roll Video

Supplemental video of manufacturing Paxlovid.

Stay up to date on the latest news and alerts through the Pfizer Wire

Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

 

Sign Up Now